Companies / CAN

CANN GROUP LIMITED

ASX:CANPharmaceuticals, Biotechnology & Life Sciences
1.66B shares on issueASX (delayed) · as of 28 July 2026$0.003price · delayed$5.0Mmarket cap · indicative
F
Dilution grade

Runway under 2 quarters; share count grew 256% in 24 months; 8 cash raises in 24 months

Cash runway-1.1 quarters of funding
Share-count growth (24m)255.6%
Raise cadence (24m)8 cash raises
Options & rights overhang16.6% of shares
In-the-money supply0.0% of shares
Pending proposed issuesnone

CANN GROUP LIMITED's ordinary share count grew 255.6% between July 2024 and June 2026, to 1.66B shares. The company raised capital eight times in that period for total disclosed proceeds of A$16.9M, most recently a A$750K Placement (Convertible securities facility) in March 2026. Options and rights on issue could convert into 275M new shares, equal to 16.6% of the current share count, with the nearest expiry in November 2026 and 0% currently in the money. At the March 2026 quarter the company reported available cash of A$-1.5M, equal to -1.1 quarters of cover. No proposed securities issues (Appendix 3B) are pending.

AI-generated summary of this page's cited filings · updated 28 July 2026
Email me when this grade changes
Alerts are coming soon — this opens a pre-filled email that puts you on the list.
16.6%
Max option dilution
0.0%
ITM option dilution
2
Raises · last 12 months
-1.1 qtrs
Cash cover · under 2 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Latest count 1.66B per ASX (delayed) (28 July 2026).
0.77B1.10B1.42BDec 24Sept 25July 26Cash raise · 16 Mar 2026Cash raise · 22 Oct 2025Cash raise · 7 Apr 2025Cash raise · 3 Apr 2025Cash raise · 11 Mar 2025Cash raise · 6 Mar 2025

Cash runway

-1.1 qtrs
Less than two quarters of funding at the recent spend rate — near-term funding pressure.
$-1.5M available cash at quarter ended 31 Mar 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds.
Paid plan
Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 31 Mar 2026.
Join the waitlist

Issuance timeline

Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityTotal on issue afterSource
6 July 20263H · cancellationCAN : ORDINARY FULLY PAID1.66BAppendix 3H
18 June 20262A · quoted issueCAN : ORDINARY FULLY PAID1.66BAppendix 2A
22 May 20262A · quoted issueCAN : ORDINARY FULLY PAID1.64BAppendix 2A
1 May 20262A · quoted issueCAN : ORDINARY FULLY PAID1.63BAppendix 2A
15 Apr 20262A · quoted issueCAN : ORDINARY FULLY PAID1.61BAppendix 2A
Paid plan
Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Join the waitlist

Capital raises

8 cash raises in the last 24 months · 2 in the last 12 months

$750k
Placement (Convertible securities facility)
16 Mar 2026 ACTIVE
Paid plan
Full raise history
Issue price, discount, brokers, purpose and tranche detail for every raise on record.
Join the waitlist

Pending proposed issues

No proposed issues (Appendix 3B) currently pending.

Options & convertible securities

16.6%
Total overhang · of current shares
0.0%
In the money · at current price
275.4M
Potential new shares
Nov 2026
Nearest expiry
Paid plan
Per-line options & expiry cliffs
Each option line — code, strike, expiry, quantity and ITM value — plus the expiry-cliff chart.
Join the waitlist

Director dealings

DateDirectorTypeSharesOptionsValueSource
24 Dec 2025Jenni PilcherOther4.8M13.4M—3Y notice
24 Dec 2025Mike RyanOther2.6M2.6M—3Y notice
10 Dec 2025Doug RathboneOther—600k—3Y notice
Paid plan
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Join the waitlist

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Sign up free — coming soon

Latest announcements

13 July 2026Change of Auditor
6 July 2026Notification of cessation of securities - CAN
3 July 2026$PIncrease to Private Credit Loan Facility
29 June 2026$PEarly Redemption of Convertible Notes
29 June 2026Ceasing to be a substantial holder
18 June 2026Application for quotation of securities - CAN
26 May 2026Change in substantial holding
22 May 2026Application for quotation of securities - CAN
10 May 2026Final Director's Interest Notice
4 May 2026$PCann announces leadership transition
1 May 2026Application for quotation of securities - CAN
28 Apr 2026$PQuarterly Activities/Appendix 4C Cash Flow Report
15 Apr 2026Application for quotation of securities - CAN
20 Mar 2026Change in substantial holding
18 Mar 2026Cleansing Notice
18 Mar 2026Notification regarding unquoted securities - CAN
18 Mar 2026Cleansing Notice
18 Mar 2026Application for quotation of securities - CAN
16 Mar 2026Proposed issue of securities - CAN
15 Mar 2026$PCann Raises $750k via Convertible Note

Headlines link to the source PDFs on the ASX announcements platform. Data as of 28 July 2026.